| Sadra Sasha Jazayeri, MD | |
|
4045 E Bell Rd Ste 125, Phoenix, AZ 85032-2238 | |
| (602) 971-0268 | |
| (602) 971-1556 |
| Full Name | Sadra Sasha Jazayeri |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 25 Years |
| Location | 4045 E Bell Rd Ste 125, Phoenix, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700893864 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 30789 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alliance Dermatology And Mohs Center Pc | 7113144510 | 7 |
News Archive
As the Senate Finance Committee prepares to vote on the amended health care reform package, members of the American Society of Transplantation (AST) arrived on Capitol Hill armed with a letter encouraging the Senate to adopt a health care provision that will extend Medicare's coverage of post-transplant drugs, which are critical to maintaining the health of the transplant patient. Immunosuppressive drugs are currently covered for a period of 36 months.
A new targeted therapy for prostate cancer halts tumor growth in animals with advanced prostate cancer that is resistant to hormone therapy, a new study finds. The results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.
A new study provides important insight into the mechanisms involved in resistance to treatment of breast cancer patients with trastuzumab (Herceptin). The research, published by Cell Press in the October issue of the journal Cancer Cell , identifies markers that may help to identify patients who are unlikely to respond to trastuzumab treatment and provides a potential strategy for treating these patients.
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect. Currently, lung cancer researchers are limited to using RNA extracted from early-stage tumors removed during surgery. The small quantities of tissue extracted during routine diagnostic biopsies have not been useful to researchers, due to their small size and the variety of ways they have been processed.
› Verified 6 days ago
| Entity Name | Alliance Dermatology & Mohs Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861813156 PECOS PAC ID: 7113144510 Enrollment ID: O20140807002627 |
News Archive
As the Senate Finance Committee prepares to vote on the amended health care reform package, members of the American Society of Transplantation (AST) arrived on Capitol Hill armed with a letter encouraging the Senate to adopt a health care provision that will extend Medicare's coverage of post-transplant drugs, which are critical to maintaining the health of the transplant patient. Immunosuppressive drugs are currently covered for a period of 36 months.
A new targeted therapy for prostate cancer halts tumor growth in animals with advanced prostate cancer that is resistant to hormone therapy, a new study finds. The results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.
A new study provides important insight into the mechanisms involved in resistance to treatment of breast cancer patients with trastuzumab (Herceptin). The research, published by Cell Press in the October issue of the journal Cancer Cell , identifies markers that may help to identify patients who are unlikely to respond to trastuzumab treatment and provides a potential strategy for treating these patients.
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect. Currently, lung cancer researchers are limited to using RNA extracted from early-stage tumors removed during surgery. The small quantities of tissue extracted during routine diagnostic biopsies have not been useful to researchers, due to their small size and the variety of ways they have been processed.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sadra Sasha Jazayeri, MD 4045 E Bell Rd, 125, Phoenix, AZ 85032 Ph: (602) 971-0268 | Sadra Sasha Jazayeri, MD 4045 E Bell Rd Ste 125, Phoenix, AZ 85032-2238 Ph: (602) 971-0268 |
News Archive
As the Senate Finance Committee prepares to vote on the amended health care reform package, members of the American Society of Transplantation (AST) arrived on Capitol Hill armed with a letter encouraging the Senate to adopt a health care provision that will extend Medicare's coverage of post-transplant drugs, which are critical to maintaining the health of the transplant patient. Immunosuppressive drugs are currently covered for a period of 36 months.
A new targeted therapy for prostate cancer halts tumor growth in animals with advanced prostate cancer that is resistant to hormone therapy, a new study finds. The results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.
A new study provides important insight into the mechanisms involved in resistance to treatment of breast cancer patients with trastuzumab (Herceptin). The research, published by Cell Press in the October issue of the journal Cancer Cell , identifies markers that may help to identify patients who are unlikely to respond to trastuzumab treatment and provides a potential strategy for treating these patients.
Analyzing the genes expressed by cancer cells allows for a better understanding of that patient's specific disease and in turn, a more personalized approach to treatment. But obtaining the RNA from a tumor in the lungs in order to conduct the genetic analysis is a challenging prospect. Currently, lung cancer researchers are limited to using RNA extracted from early-stage tumors removed during surgery. The small quantities of tissue extracted during routine diagnostic biopsies have not been useful to researchers, due to their small size and the variety of ways they have been processed.
› Verified 6 days ago
Dr. Stella Xiang Chen, MD Dermatology Medicare: Medicare Enrolled Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-301-8000 | |
Christopher Bengson, M.D., M.H.S. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4212 N 16th St, Phoenix, AZ 85016 Phone: 602-263-1200 Fax: 602-200-5383 | |
Dr. Karen Taraszka Hastings, MD, PHD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 650 E Indian School Rd, Dermatology Clinic/copper Clinic, Phoenix, AZ 85012 Phone: 602-277-5551 | |
Dr. David Israel Andrews, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1919 E Thomas Rd, Phoenix, AZ 85016 Phone: 602-933-0895 Fax: 602-933-2436 | |
Richard George Bottiglione, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4045 E Bell Rd, 125, Phoenix, AZ 85032 Phone: 602-971-0268 Fax: 602-971-1556 | |
Amanda Carroll Rainwater, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 11130 N Tatum Blvd, #100, Phoenix, AZ 85028 Phone: 602-494-1817 Fax: 602-494-7103 | |
Dr. Kenneth Stephen Bistricky, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 650 E Indian School Rd, Phoenix, AZ 85012 Phone: 602-277-5551 |